COST-EFFECTIVENESS ANALYSIS OF DIAGNOSTICS OF TUBERCULOSIS INFECTION IN THE RUSSIAN FEDERATION WITH THE USE OF TUBERCULOUS RECOMBINANT ALLERGEN

被引：0
|
作者：
Holownia, M. [1 ]
Solodun, I [1 ]
Bashlakova, E. [1 ]
Ermolaeva, T. [1 ]
Davydovskaya, M. [1 ]
Evdoshenko, E. [1 ]
机构：
[1] Moscow Dept Healthcare, State Budgetary Inst Moscow City, Ctr Clin Trials Management & Performance, Moscow, Russia
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.1997
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD56
引用
收藏
页码：A694 / A694
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of diagnostic technologies for mycobacterium tuberculosis infection in India and Brazil
    Bashir, Saima
    Ali, Shehzad
    Yerlikaya, Seda
    Gaeddert, Mary
    Gosce, Lara
    Rangaka, Molebogeng X.
    Denkinger, Claudia M.
    PLOS GLOBAL PUBLIC HEALTH, 2024, 4 (11):
  • [32] Costs and Cost-effectiveness of Four Treatment Regimens for Latent Tuberculosis Infection
    Holland, David P.
    Sanders, Gillian D.
    Hamilton, Carol D.
    Stout, Jason E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (11) : 1055 - 1060
  • [33] Challenges and Opportunities for Use of Cost-Effectiveness Analysis
    Yabroff, K. Robin
    Schrag, Deborah
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (17): : 1161 - U11
  • [34] PHARMACOECONOMIC STUDY OF BOTULINIUM TOXIN TYPE A IN TREATMENT OF POST-STROKE SPASTICITY IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS ANALYSIS
    Yagudina, R.
    Kulikov, A.
    Ugrekhelidze, D.
    VALUE IN HEALTH, 2014, 17 (07) : A395 - A395
  • [35] COST-EFFECTIVENESS ANALYSIS OF CEREBROLYSIN IN THE TREATMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE MODERATE AND SEVERE DEGREES OF SEVERITY IN THE RUSSIAN FEDERATION
    Kulikov, A.
    Abdrashitova, G.
    VALUE IN HEALTH, 2015, 18 (07) : A705 - A705
  • [36] THE USE OF DALYS AND QALYS IN COST-EFFECTIVENESS ANALYSIS
    Deshmukh, A. A.
    Chen, A.
    Sonawane, K. B.
    Cantor, S. B.
    VALUE IN HEALTH, 2013, 16 (03) : A270 - A270
  • [37] COST-EFFECTIVENESS ANALYSIS OF BOSENTAN AND SILDENAFIL COMPARED WITH STANDARD THERAPY IN TREATMENT OF PRIMARY PULMONARY ARTERIAL HYPERTENSION IN RUSSIAN FEDERATION
    Omelyanovsky, V
    Avxentyeva, M.
    Krysanov, I
    Goryaynov, S.
    Ivakhnenko, O.
    Tsfasman, F. M.
    VALUE IN HEALTH, 2011, 14 (07) : A367 - A367
  • [38] Cost-effectiveness recombinant factor VIIa use in orthotopic liver transplant
    Schoenhaus, R.
    Awdishu, L.
    Daniels, C.
    VALUE IN HEALTH, 2008, 11 (03) : A85 - A85
  • [39] COST - EFFECTIVENESS ANALYSIS OF BUDESONID EASYHALER IN THE TREATMENT OF ASTHMA IN CHILDREN IN THE RUSSIAN FEDERATION
    Kulikov, A.
    Kilimanova, E.
    VALUE IN HEALTH, 2015, 18 (07) : A501 - A501
  • [40] Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis
    Haukaas, Fredrik Salvesen
    Arnesen, Trude Margrete
    Winje, Brita Askeland
    Aas, Eline
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2017, 18 (04): : 405 - 415
12345